ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Sanaria® PfSPZ-CVac vaccine 75 percent effective at preventing malaria
June 11, 2021Clinical studies optimising immunisation with Sanaria’s PfSPZ-CVac vaccine resulted in 77 and 75 percent of participants being protected from malaria infection. -
Novel vaccination regimen shown to be effective in preventing malaria
May 07, 2021A three-dose regimen of Plasmodium falciparum sporozoites under chemoprophylaxis (PfSPZ-CVac) was shown to be safe, well tolerated and highly effective in a Phase II trial. -
The Govt. of EG, US Energy Companies & Sanaria collaborate for malaria vaccine
April 15, 2019The collaboration is to extend support for clinical development of PfSPZ vaccine for malaria and a pathway towards malaria elimination on Bioko Island -
Cryoport Expands Agreement with Sanaria
June 08, 2017Agrees to develop cold chain logistics models for malaria vaccine
Pharma Sources Insight January 2025
